In 2017, the global antacid market size was valued at $5.83 billion and is projected to expand at a CAGR of 3% during the forecast period. Changes in eating habits are one of the major factors expected to drive growth over the forecast period.
The increasing prevalence of gastroesophageal reflux disease (GERD) is expected to impact the overall market during the forecast period. According to the journal Gut published by the International Foundation for Gastrointestinal Disorders, in 2017 the prevalence of GERD was approximately 18% to 28% in North America, 9% to 26% in Europe, and 3% to 8% in East Asia, from 9% to 33% in the Middle East, 12% in Australia and 23% in South America.
A full report of Global Antacids Market available at: https://www.orionmarketreports.com/antacid-market/11646/
Global Antacids Market Segmentation
By Formulation Type
• Tablet
• Powder
• Others
By Distribution Channel
• Hospital Pharmacies
• E-Commerce
• Others
Major Players
• GlaxoSmithKline PLC
• Sun Pharmaceuticals Ltd
• Sanofi S.A
• Bayer AG
• Johnson & Johnson
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
